UnknownPhase 2/3

Improving Patient Outcome in Group Therapy for Eating Disorders

Denmark159 participantsStarted 2012-08

Plain-language summary

The current trial aims to investigate the impact of continuous feedback on dropout and outcome in group therapy. The hypothesis is that continuous feedback to patient and therapist on treatment progress and alliance will 1) increase adherence and 2) increase treatment outcome.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged 18 or older. * BMI of minimum 20. * Meet the diagnostic criteria for Bulimia Nervosa, Binge Eating Disorder or EDNOS according to DSM- IV. Exclusion Criteria: * Acute suicidal risk. * Psychosis. * Severe depression. * Abuse of alcohol, medicine and/or narcotics up to 3 months before referral. * Use of cannabis once a month is accepted at intake but must stop during treatment. * Concomitant psychotherapeutic/ psychiatric treatment outside Stolpegaard Psychotherapy Centre. * Severe or non-regulated physical co-morbidity. * Pregnancy. * Unable to understand Danish. * Previous participation in the current trial. * Considered unable to attend treatment sessions as planned. * Lack of informed consent.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Adherence

Timeframe: At end of treatment. Participants will be followed for the duration of treatment, an expected average of 20 weeks.

Trial details

NCT IDNCT01693237

SponsorMarianne Lau, MD, DSci.

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2014-08

View on ClinicalTrials.gov More Bulimia Nervosa (BN) trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.